Francesca Buttini

Parma, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis.

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis.

Journal: Expert opinion on drug delivery
Published: August 30, 2026

Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus.

Inhaled product dissolution as a predictive tool of drug bioavailability: a p38 MAPK inhibitor case study using Respicell® dissolution apparatus.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 19, 2026

A lidocaine dry powder inhaler to modulate cough: particle engineering and human proof-of-concept.

A lidocaine dry powder inhaler to modulate cough: particle engineering and human proof-of-concept.

Journal: International journal of pharmaceutics
Published: May 21, 2026

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

Journal: Pharmaceutics
Published: April 08, 2026

Integrating In Vitro Performance and In Vivo Patient-Reported Outcomes of a Mometasone Furoate Nasal Spray Device: A Translational Evaluation.

Integrating In Vitro Performance and In Vivo Patient-Reported Outcomes of a Mometasone Furoate Nasal Spray Device: A Translational Evaluation.

Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: February 04, 2026

The isolated perfused lung: a bridge between in vitro and in vivo studies of inhaled medicinal products.

The isolated perfused lung: a bridge between in vitro and in vivo studies of inhaled medicinal products.

Journal: AAPS PharmSciTech
Published: October 25, 2025

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Journal: International journal of biological macromolecules
Published: October 16, 2025

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.

Journal: International journal of biological macromolecules
Published: October 16, 2025

Profile of the Respimat soft mist inhaler for chronic obstructive pulmonary disease treatment: overview of its safety and efficacy.

Profile of the Respimat soft mist inhaler for chronic obstructive pulmonary disease treatment: overview of its safety and efficacy.

Journal: Expert review of medical devices
Published: August 28, 2025

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms.

Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 01, 2025

Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways.

Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways.

Journal: Drug delivery and translational research
Published: June 28, 2025

Editorial: Pulmonary drug delivery.

Editorial: Pulmonary drug delivery.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 13, 2024
Showing 1-12 of 97

Last Updated: 09/26/2026